Coronary artery bypass graft surgery versus percutaneous coronary intervention in unprotected left main coronary artery disease: A systematic review
- 1 January 2020
- journal article
- review article
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 21 (1), 65-73
- https://doi.org/10.31083/j.rcm.2020.01.590
Abstract
Critical lesion of the unprotected left main coronary disease carries a tremendous mortality burden, often associated with a diabetes status or multivessel disease, with coronary artery bypass grafting being the standard treatment for over 40 years. Percutaneous coronary intervention with drug eluting stents should be taken into consideration and could be a better option for patients with low SYNTAX score as validated by the recently published studies. This review summarizes the major randomized clinical trials and meta-analyses concerning the debate regarding percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting for unprotected left main coronary disease, along with the latest European and American revascularization guidelines and tries to shed light on this matter. The most results advocate that there is no convincing difference in survival rate for both therapies, especially in patients with isolated left main disease but with fewer major ischemic events for coronary artery bypass grafting when compared with percutaneous coronary intervention in multivessel coronary artery disease, at the rate of a higher stroke incidence. The gaps in evidence are also highlighted, especially the lack of randomized clinical trials with new generation drug eluting stents versus coronary artery bypass grafting or those regarding the best revascularization strategy for an acute coronary syndrome when unprotected left main coronary disease is involved.Keywords
This publication has 31 references indexed in Scilit:
- Five-Year Outcomes in Patients With Left Main Disease Treated With Either Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery TrialCell Metabolism, 2014
- Percutaneous Coronary Intervention Versus Coronary Bypass Surgery in United States Veterans With DiabetesJournal of the American College of Cardiology, 2013
- Strategies for Multivessel Revascularization in Patients with DiabetesNew England Journal of Medicine, 2012
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary InterventionJournal of the American College of Cardiology, 2011
- Randomized Comparison of Percutaneous Coronary Intervention With Sirolimus-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Stem StenosisJournal of the American College of Cardiology, 2011
- Sex Differences in Mortality Associated With Computed Tomographic Angiographic Measurements of Obstructive and Nonobstructive Coronary Artery DiseaseCirculation: Cardiovascular Imaging, 2010
- Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) TrialCirculation, 2010
- Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting StentsJournal of the American College of Cardiology, 2008
- Acute and Late Outcomes of Unprotected Left Main Stenting in Comparison With Surgical RevascularizationJournal of the American College of Cardiology, 2008
- Propensity Analysis of Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease and High-Risk FeaturesCell Metabolism, 2004